Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.260
-0.010 (-0.44%)
Dec 23, 2024, 2:55 PM EST - Market open

Genelux Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Revenue
0.010.1711.07---
Revenue Growth (YoY)
-96.64%-98.46%----
Gross Profit
0.010.1711.07---
Selling, General & Admin
12.3211.5758.296.23.34
Research & Development
16.6412.779.086.326.237.53
Operating Expenses
28.9624.3414.0814.6112.4210.87
Operating Income
-28.95-24.17-3.01-14.61-12.42-10.87
Interest Expense
-0.01-0.82-1.41-1.42-1.22-0.76
Interest & Investment Income
1.30.24----
Other Non Operating Income (Expenses)
--3.15--0.4--
EBT Excluding Unusual Items
-27.66-27.9-4.42-16.43-13.64-11.63
Other Unusual Items
--0.40.310.05--
Pretax Income
-27.66-28.3-4.11-16.38-13.64-11.63
Income Tax Expense
--1.1---
Net Income
-27.66-28.3-5.21-16.38-13.64-11.63
Net Income to Common
-27.66-28.3-5.21-16.38-13.64-11.63
Shares Outstanding (Basic)
30249988
Shares Outstanding (Diluted)
30249988
Shares Change (YoY)
47.42%167.97%0.92%8.05%7.66%-
EPS (Basic)
-0.94-1.16-0.57-1.81-1.63-1.50
EPS (Diluted)
-0.94-1.16-0.57-1.81-1.63-1.50
Free Cash Flow
-24.36-21.3-3.62-6.59-7.23-8.99
Free Cash Flow Per Share
-0.83-0.87-0.40-0.73-0.86-1.16
Gross Margin
100.00%100.00%100.00%---
Operating Margin
-361862.50%-14214.71%-27.22%---
Profit Margin
-345750.00%-16645.29%-47.05%---
Free Cash Flow Margin
-304550.00%-12529.41%-32.71%---
EBITDA
-28.68-23.67-2.46-14.06-11.87-10.49
EBITDA Margin
---22.23%---
D&A For EBITDA
0.270.50.550.550.550.38
EBIT
-28.95-24.17-3.01-14.61-12.42-10.87
EBIT Margin
---27.22%---
Source: S&P Capital IQ. Standard template. Financial Sources.